Brooks Biomedical Consulting LLC is categorized under Biological Research in New York City, NY and active since 2001.
Brooks Biomedical Consulting LLC was established in 2001, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Andrew Brooks at the company’s single location by writing to 410 East 57th St Apartment 7a, New York City, New York NY 10022 or by phoning (732) 910-3178. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Brooks Biomedical Consulting LLC |
Contact Person: | Andrew Brooks |
Address: | 410 East 57th St Apartment 7a, New York City, New York 10022 |
Phone Number: | (732) 910-3178 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Biological Research |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Brooks Biomedical Consulting LLC was started in 2001 to provide professional Biological Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Andrew Brooks for inquiries that concern Brooks Biomedical Consulting LLC by calling the company number (732) 910-3178, as your correspondence is most welcome. Additionally, the physical location of the single location of Brooks Biomedical Consulting LLC can be found at the coordinates 40.758124,-73.96285 as well as the street address 410 East 57th St Apartment 7a in New York City, New York 10022.
For its online presence, you may visit Brooks Biomedical Consulting LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.